Cartasteine
- Level
- Commodity
- Parent
- 51162700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162707This classification denotes a mucolytic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) E3N11DY0TA. European Medicines Agency schedules Cartasteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06148MIG. Cartasteine generally arises in the molecular formula C9H14N2O4S2. The term CARTASTEINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 9, no. 3, 1995, list 35.) CARTASTEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cartasteine under HS 29341000 and SITC 51579. As of Q4 2014, CARTASTEINE remains US FDA's Preferred Term for this commodity. Cartasteine bears US NLM identifiers UMLS ID C2699126 and NCI Concept Code C77597. SMILES: S1CC(N(C1)C(=O)CNC(=O)C(S)C)C(=O)O.
Same parent
Under 51162700 · 48Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.